Literature DB >> 34186028

Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders.

Anna R Duncan1, Maya M Polovitskaya2, Héctor Gaitán-Peñas3, Sara Bertelli4, Grace E VanNoy5, Patricia E Grant6, Anne O'Donnell-Luria7, Zaheer Valivullah8, Alysia Kern Lovgren8, Elaina M England9, Emanuele Agolini10, Jill A Madden11, Klaus Schmitz-Abe12, Amy Kritzer13, Pamela Hawley13, Antonio Novelli10, Paolo Alfieri14, Giovanna Stefania Colafati15, Dagmar Wieczorek16, Konrad Platzer17, Johannes Luppe17, Margarete Koch-Hogrebe18, Rami Abou Jamra17, Juanita Neira-Fresneda19, Anna Lehman20, Cornelius F Boerkoel20, Kimberly Seath20, Lorne Clarke20, Yvette van Ierland21, Emanuela Argilli22, Elliott H Sherr22, Andrea Maiorana23, Thilo Diel24, Maja Hempel25, Tatjana Bierhals25, Raúl Estévez3, Thomas J Jentsch26, Michael Pusch27, Pankaj B Agrawal28.   

Abstract

The genetic causes of global developmental delay (GDD) and intellectual disability (ID) are diverse and include variants in numerous ion channels and transporters. Loss-of-function variants in all five endosomal/lysosomal members of the CLC family of Cl- channels and Cl-/H+ exchangers lead to pathology in mice, humans, or both. We have identified nine variants in CLCN3, the gene encoding CIC-3, in 11 individuals with GDD/ID and neurodevelopmental disorders of varying severity. In addition to a homozygous frameshift variant in two siblings, we identified eight different heterozygous de novo missense variants. All have GDD/ID, mood or behavioral disorders, and dysmorphic features; 9/11 have structural brain abnormalities; and 6/11 have seizures. The homozygous variants are predicted to cause loss of ClC-3 function, resulting in severe neurological disease similar to the phenotype observed in Clcn3-/- mice. Their MRIs show possible neurodegeneration with thin corpora callosa and decreased white matter volumes. Individuals with heterozygous variants had a range of neurodevelopmental anomalies including agenesis of the corpus callosum, pons hypoplasia, and increased gyral folding. To characterize the altered function of the exchanger, electrophysiological analyses were performed in Xenopus oocytes and mammalian cells. Two variants, p.Ile607Thr and p.Thr570Ile, had increased currents at negative cytoplasmic voltages and loss of inhibition by luminal acidic pH. In contrast, two other variants showed no significant difference in the current properties. Overall, our work establishes a role for CLCN3 in human neurodevelopment and shows that both homozygous loss of ClC-3 and heterozygous variants can lead to GDD/ID and neuroanatomical abnormalities.
Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CLCN; acidification; gain of function; hippocampus; intellectual disability; neurodevelopmental delay; pH sensitivity; voltage gated chloride channel

Mesh:

Substances:

Year:  2021        PMID: 34186028      PMCID: PMC8387284          DOI: 10.1016/j.ajhg.2021.06.003

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.043


  57 in total

1.  ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells.

Authors:  W Günther; A Lüchow; F Cluzeaud; A Vandewalle; T J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

2.  On the mechanism of gating charge movement of ClC-5, a human Cl(-)/H(+) antiporter.

Authors:  Giovanni Zifarelli; Silvia De Stefano; Ilaria Zanardi; Michael Pusch
Journal:  Biophys J       Date:  2012-05-02       Impact factor: 4.033

3.  Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation.

Authors:  Stefanie Weinert; Sabrina Jabs; Chayarop Supanchart; Michaela Schweizer; Niclas Gimber; Martin Richter; Jörg Rademann; Tobias Stauber; Uwe Kornak; Thomas J Jentsch
Journal:  Science       Date:  2010-06-11       Impact factor: 47.728

4.  ClC-3 chloride channels facilitate endosomal acidification and chloride accumulation.

Authors:  Mariko Hara-Chikuma; Baoxue Yang; N D Sonawane; Sei Sasaki; Shinichi Uchida; A S Verkman
Journal:  J Biol Chem       Date:  2004-10-25       Impact factor: 5.157

5.  Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.

Authors:  Mallorie Poët; Uwe Kornak; Michaela Schweizer; Anselm A Zdebik; Olaf Scheel; Sabine Hoelter; Wolfgang Wurst; Anja Schmitt; Jens C Fuhrmann; Rosa Planells-Cases; Sara E Mole; Christian A Hübner; Thomas J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

6.  A cation counterflux supports lysosomal acidification.

Authors:  Benjamin E Steinberg; Kassidy K Huynh; Alexandre Brodovitch; Sabrina Jabs; Tobias Stauber; Thomas J Jentsch; Sergio Grinstein
Journal:  J Cell Biol       Date:  2010-06-21       Impact factor: 10.539

7.  A common molecular basis for three inherited kidney stone diseases.

Authors:  S E Lloyd; S H Pearce; S E Fisher; K Steinmeyer; B Schwappach; S J Scheinman; B Harding; A Bolino; M Devoto; P Goodyer; S P Rigden; O Wrong; T J Jentsch; I W Craig; R V Thakker
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

8.  ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function.

Authors:  Philipp F Lange; Lena Wartosch; Thomas J Jentsch; Jens C Fuhrmann
Journal:  Nature       Date:  2006-03-09       Impact factor: 49.962

9.  Design, function and structure of a monomeric ClC transporter.

Authors:  Janice L Robertson; Ludmila Kolmakova-Partensky; Christopher Miller
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

10.  Large transient capacitive currents in wild-type lysosomal Cl-/H+ antiporter ClC-7 and residual transport activity in the proton glutamate mutant E312A.

Authors:  Michael Pusch; Giovanni Zifarelli
Journal:  J Gen Physiol       Date:  2021-01-04       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.